By exploring the Oncomine database, PURα mRNA levels were significantly lower in HRPC samples than in Hormone-naive Prostate Cancer (HNPC) samples in a large cohort (Wang et al. 2008). The gene discussed is PURA; the disease is prostate carcinoma.